Nature and The Economist reported on the research.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Rising chronic disease rates and an aging population in the USA are driving unprecedented demand for syringe filling machines ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

The MiDe systems, inspired by squid propulsion, demonstrate effective needle-free drug delivery in the gastrointestinal tract ...

could be used at home. While small, swallowable devices aren’t new, similar devices with these needleless microjet systems ...

Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous ...

Here’s how it works: By mimicking a natural hormone called GLP-1, it helps regulate insulin production ... approved for any use by the FDA. The FDA does not verify the safety of effectiveness ...

Rachel pointed to her exclusive from earlier in the summer on who really came up with the idea for $35 insulin ... be used to educate docs, critics say Squid-inspired replacements for needles ...